Insights from 2024 ESGO Annual Meeting


 

ESGO 2024 Insights: "COPELIA Trial - Cediranib With Weekly Paclitaxel or Olaparib vs. Weekly Paclitaxel Chemo for Advanced/Recurrent Endometrial Cancer"

117 views
March 22, 2024
0 Comments
Login to view comments. Click here to Login
Videos